Navigation Links
Researchers developing new multiple sclerosis drug that can be taken orally
Date:7/10/2012

The Department of Defense (DoD) has awarded SRI International a one-year grant to develop a novel therapy for multiple sclerosis (MS), an autoimmune nervous system disease that affects about 400,000 people in the United States and more than two million people worldwide. There is currently no cure for this disorder, which can impair vision and movement.

The grant, funded through DoD's Congressionally Directed Medical Research Programs, will support the development of an oral drug that targets miR-326, a molecule recently found to stimulate the production of immune system mediators known as T-helper 17 (Th17) cells. Patients with MS have high levels of miR-326, and Th17 is thought to play a critical role in causing MS and other autoimmune diseases. The new therapy will inhibit miR-326 and block the production of Th17 cells.

The novel, orally administered drug will be more convenient for patients than currently available treatments. MS treatments today often require frequent hospital visits for injections or intravenous infusions. The new drug could also help patients who do not respond to existing medications, or who experience significant side effects as a result of taking them.

"New and more convenient and effective therapeutics for multiple sclerosis are greatly needed," said Jennifer Lam, Ph.D., a research scientist in SRI's Biosciences Division who is spearheading the project. "Our research is directed toward the development of a novel oral therapeutic as well as a deeper understanding of the mechanisms that contribute to MS."

The project described was supported by Award Numbers W81XWH-11-1-0736 from the U.S. Army Medical Research Acquisition Activity. The content of the information does not necessarily reflect the position or the policy of the Government, and no official endorsement should be inferred.


'/>"/>

Contact: Dina Basin
dina.basin@sri.com
650-859-3845
SRI International
Source:Eurekalert

Page: 1

Related medicine news :

1. UMass Amherst researchers unravel secrets of parasites replication
2. U-M researchers identify new genetic cause for chronic kidney disease
3. Researchers develop secure protocol for linking data registries for HPV surveillance
4. $53 million grant will help health researchers develop new therapies -- with the publics help
5. Researchers find new target deep within cancer cells
6. Researchers offer new approach to track former prisoners access to community HIV care
7. UTHealth, French researchers discover gene defect for new syndrome
8. New Facebook app to detect pedophiles and criminals developed by Ben-Gurion U. researchers
9. BWH researchers discover new vaccine candidate for Pseudomonas aeruginosa
10. Researchers will employ microscopic clay minerals to design more efficient and less toxic drugs
11. Tufts Medical Center researchers receive $10 million NIH grant to test blood clot prevention drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/24/2017)... Caicos Islands, BWI (PRWEB) , ... September 24, 2017 , ... ... #1 rated resort on TripAdvisor and one of Provo's premier boutique resorts, is planning ... structural damage to the resort after devastating Hurricanes Irma and more recently Hurricane Maria, ...
(Date:9/24/2017)... (PRWEB) , ... September 24, 2017 , ... In “Sky and I”, a young boy was walking home and feeling ... friend who tells him otherwise. The new friend says he can do whatever he wants ... special and good enough just the way he is. God created him with special talents ...
(Date:9/23/2017)... Los Angeles, California (PRWEB) , ... September 23, ... ... Chicago Tribune discusses the behavioral approach to fighting obesity of Robert Kushner, director ... holistic approach to weight loss and promoting healthier habits, the article notes that ...
(Date:9/22/2017)... ... September 22, 2017 , ... MEDIA OPPORTUNITY: , Save Our Hospital - ... on why they are rallying against Mayo Clinic. Specifically, media can talk to steering ... Noseworthy’s (CEO) decision to close the Albert Lea hospital. , The rally aims to ...
(Date:9/22/2017)... ... September 22, 2017 , ... Fenwick Agency of Plano, TX has announced the ... part of the nationally recognized ‘Agents of Change’ movement. The agency pledges to select ... leaders to seek out those who most need help. Their hope is to bring ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)... LONDON , Sept. 5, 2017  Just 18 ... Valid Insight is pleased to announce the appointment of ... Tammy Wynne , Dominic Jones-Phillips and ... from industry. ... a team of market access writers. She has over ...
(Date:9/1/2017)... 1, 2017  Bayer will present the latest research from ... Medical Oncology (ESMO) 2017 Congress, September 8-12 in ... preclinical and clinical data on Bayer,s marketed portfolio and late-stage ... "We value the ... cancer research at ESMO," said Carsten Brunn , Head ...
(Date:8/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), will ... September 11, 2017, in New York . ... is scheduled to present at 11:05 a.m. Eastern Time. ... http://ir.hill-rom.com/events.cfm . A recorded replay will be available one ... 10, 2017. About ...
Breaking Medicine Technology: